Bioventus Inc.
Bioventus Inc. (BVS) Stock Overview
Explore Bioventus Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
604.3M
P/E Ratio
26.29
EPS (TTM)
$0.33
ROE
0.14%
BVS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bioventus Inc. (BVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 52.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.22.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.29 and a market capitalization of 604.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.